Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort – Determinants and Consequences

BACKGROUND: In COPD patients of GOLD groups A and B, a high degree of treatment with inhaled corticosteroids (ICS) has been reported, which is regarded as overtreatment according to GOLD recommendations. We investigated which factors predict ICS use and which relationship it has to clinical and func...

Descripción completa

Detalles Bibliográficos
Autores principales: Lutter, Johanna I, Jörres, Rudolf A, Trudzinski, Franziska C, Alter, Peter, Kellerer, Christina, Watz, Henrik, Welte, Tobias, Bals, Robert, Kauffmann-Guerrero, Diego, Behr, Jürgen, Holle, Rolf, F Vogelmeier, Claus, Kahnert, Kathrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053704/
https://www.ncbi.nlm.nih.gov/pubmed/33883892
http://dx.doi.org/10.2147/COPD.S304532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053704/
https://www.ncbi.nlm.nih.gov/pubmed/33883892
http://dx.doi.org/10.2147/COPD.S304532

Ejemplares similares